Projects per year
Search results
-
Finished
-
ANI361: Adoptive Cell Therapy Inspired On Neo-antigens (ACTION)
1/01/24 → 31/12/24
Project: Fundamental
-
BRGRD73: POC 2023: Library sceening and hit validation for pancreatic cancer
Ballet, S., De Neve, J., Rooman, I. & Versées, W.
1/01/24 → 31/03/25
Project: Policy Based
-
ANI358: Unravelling the anti-tumor effect of autologous myeloid dendritic cel Is plus the synthetic adjuvant AS01B in solid tumors.
1/11/23 → 31/10/24
Project: Fundamental
-
ANI356: Spatial mapping of pancreatic cancer subtypes and their microenvironmental niches
1/11/23 → 31/10/24
Project: Fundamental
-
ANI365: S-adenosyl methionine synthesis as a targetable metabolic vulnerability in Multiple Myeloma
De Bruyne, E. & Wang, Y.
1/11/23 → 31/10/24
Project: Fundamental
-
ANI368: Creation of a 3D CRiMe scene to unravel Cytotoxicity Resistant Mechanisms in nonsmall cell lung cancer
1/11/23 → 31/10/24
Project: Fundamental
-
ANI315: Understanding oncolytic herpes simplex virus type-1 induced cell death mechanisms and immunogenicity.
1/01/23 → 31/12/23
Project: Fundamental
-
OZR3804: Extension of the PhD trajectory due to Covid-19 (OZR Budget)
Pierson, J., Tindemans, K., De Leu, N., Claeys, P., Coene, G., Simón, L., Raats, T., Hes, F. J., Loisen, J., Orban, A., van Heur, B., De Graeve, I., Goderis, S., Verfaillie, K., Christiaens, J., Tindemans, K., Anckaert, E., Meyer, T., Dumortier, E., Anckaert, E., Rooman, I., Cohen, J. & Gutermuth, J.
7/10/21 → 30/09/24
Project: Fundamental
-
AIIFUND73: Inequities at the end-of-life-in cancer and Dementia: A Mixed-Methods study
Van den Block, L., Gilissen, J. & Decoster, L.
1/06/21 → 30/06/23
Project: Fundamental
-
OZR3740: Bilateral cooperation within the framework of a joint doctoral project: benchfee for joint PhD VUB - KU Leuven, DE COSTER Michiel
22/10/20 → 21/10/24
Project: Fundamental
-
FWOTM1002: Development of innovative NANObody-based therapies to eradicate REsidual disease in Multiple Myeloma (acronym: NANOREMM)
1/10/20 → 31/12/23
Project: Fundamental
-
FWOSB81: Eccentric: Enhancing the function of Cancer Countering Effector cells using Nanobodies Targeting Regulatory Immune Checkpoints
Breckpot, K., Devoogdt, N., Keyaerts, M. & Awad, R. M.
1/11/19 → 31/10/23
Project: Fundamental
-
FWOSB80: Combining targeted radionuclide therapy and cancer immunotherapy to advance precision medicine through innovation.
Breckpot, K., Devoogdt, N., D'Huyvetter, M., Keyaerts, M. & Ertveldt, T.
1/11/19 → 31/10/23
Project: Fundamental
-
AIIFUND40: Junior Grant Award Agreement: Unraveling the balance of tolerance and immunogenicity of multiple myeloma cells.
1/01/19 → 31/12/19
Project: Fundamental
-
FWOTM900: Modulating epigenetic mechanisms to enhance cancer immunotherapy.
Breckpot, K., De Beck, L. & Maes, K.
1/10/18 → 30/09/22
Project: Fundamental
-
OZR3286: Bilateral cooperation within the framework of a joint doctoral project: Bench Fee for Joint PhD VUB-UGent, Vlummens Philip
13/02/18 → 31/12/22
Project: Fundamental
-
FWOKN297: Targeting residual, dormant cancer cells in myeloma: a new approach
De Veirman, K. & Vanderkerken, K.
1/01/18 → 31/12/18
Project: Fundamental
-
SRP48: Strategic Research Programme: Cancer Cell Targeting in Myeloma and Melanoma (MyMe)
Vanderkerken, K., Thielemans, K., Vanderkerken, K. & Breckpot, K.
1/11/17 → 31/10/24
Project: Fundamental
-
ANI172: Effects of transcutaneous vagal nerve stimulation on radiation-induced inflammation and prognosis of patients with lung cancer.
De Grève, J. & Gidron, Y.
1/10/16 → 30/09/20
Project: Fundamental
-
FWOODYS12: De-convolution of tumour biology in the post-genomic era: focus on pancreatic cancer
1/10/16 → 1/10/21
Project: Fundamental
-
-
ANI165: Immune checkpoint modulation in multiple myeloma: can iNKT cells be targeted? Afwerkbeurs toegekend aan Mérédis Favreau.
Vanderkerken, K., Menu, E. & Favreau, M.
1/09/16 → 31/08/17
Project: Fundamental
-
OZR3022: Bilaterale samenwerking ikv gemeenschappelijk doctoraatsproject: Bench Fee voor Joint PhD VUB-UGent, Schreuer Max
18/05/16 → 30/09/19
Project: Fundamental
-
FWOAL806: Modulation of the tumor micro-environment in Multiple Myeloma, are exosomes involved?
1/01/16 → 31/12/19
Project: Fundamental
-
FWOTM771: Exosomal communication in Multiple Myeloma: friend or foe?
1/10/15 → 30/09/19
Project: Fundamental
-
OZR2225: Interaction between embryo and natural killer cells in the endometrium: role at implantation disorders
1/10/11 → 31/12/11
Project: Fundamental
-
OZR2103: Tumor-microenvironmental interactions in multiple myeloma: regulation by epigenetic changes and hypoxia
1/01/11 → 31/12/14
Project: Fundamental
-
FWOKN235: Pre-clinical evaluation of NKT-cells in multiple myeloma
1/01/11 → 31/12/11
Project: Fundamental
-
ANI71: Epigenetic regulation and multiple myeloma: identification of potential targets.
De Bruyne, E. & Vanderkerken, K.
1/01/11 → 31/12/12
Project: Fundamental
-
FWOKN234: The interest of aldehyde dehydrogenase positive cells in the evolution of multiple myeloma
Van Valckenborgh, E. & Vanderkerken, K.
1/01/11 → 31/12/11
Project: Fundamental
-
ADSI233: Biological aspects and therapeutical use of mesenchymal stem cells in Multiple Myeloma
1/10/10 → 31/12/11
Project: Fundamental
-
HERC10: Fluorescence activated cell sorter for immunobiolgical applications.
Thielemans, K., Vanderkerken, K., Van Valckenborgh, E. & Aerts, J.
22/07/10 → 21/07/15
Project: Fundamental
-
ADSI234: Research Scholarship rare tumors: identification of heterogenicity in drug sensitivity at (sub)populations with multiple myeloma. (Foundation Emmanuel Van der Schueren)
Vanderkerken, K., Van Valckenborgh, E. & Vande Broek, I.
1/05/10 → 30/04/13
Project: Fundamental
-
FWOAL535: Chromosomal abnormalities in human preimplantation embryos and embryonic stem cells: causes, mechanisms and consequences for IVF and regenerative medicine
Sermon, K., Spits, C., Van De Velde, H., Liebaers, I., Jacobs, K. & Staessens, C.
1/01/10 → 31/12/13
Project: Fundamental
-
OZR1917: The role of IGF-1 in Multiple Myeloma tumor progression: effects on cell cycle and UPR response.
1/01/10 → 31/12/10
Project: Fundamental
-
OZR1921: Tumor-micro environment interactions as therapeutic target in multiple myeloma
1/01/10 → 31/12/10
Project: Fundamental
-
FWOAL568: Investigation of epigenetic stability and safety of assisted reproduction technologies
Bonduelle, M., De Vos, M., Van De Velde, H., De Rycke, M., Liebaers, I. & Van De Velde, H.
1/01/10 → 31/12/13
Project: Fundamental
-
FWOAL554: Tumor-microenvoronment interactions in multiple myeloma: regulation by epigenetic modifications and hypoxia.
Vanderkerken, K., Van Riet, I. & Menu, E.
1/01/10 → 31/12/13
Project: Fundamental
-
OZR1922: Epigenetic regulation and multiple myeloma: identification of potential targets.
1/01/10 → 31/12/13
Project: Fundamental
-
OZR1920: Identification and characterisation of the cancer stem cell in multiple myeloma.
Van Valckenborgh, E.
1/01/10 → 31/12/11
Project: Fundamental
-
HOA18: Treatment of myltiple myeloma in mice by siRNA
Vanderkerken, K., Caveliers, V., Kronenberger, P., Lahoutte, T., Muyldermans, S., Vande Broek, I. & Devoogdt, N.
1/01/09 → 31/12/12
Project: Fundamental
-
FWOAL273: Cell sorting for immunologic applications
Thielemans, K., Van Camp, B., Kooijman, R., Peters, E. & Vanderkerken, K.
1/01/04 → 31/12/04
Project: Fundamental
-
HOA1: Expansion and differentiation of embryonic and adult stem cells.
Bouwens, L., Leyns, L., Volders, M., Sermon, K., Stuy, J. & Van Riet, I.
1/01/03 → 31/12/06
Project: Fundamental
-
SF7: Molecular Mechanisms Wich Lead to Stroma-Indenpendente Growth of Myleom Cells.
1/01/97 → 31/12/00
Project: Fundamental